IXJ
iShares Global Healthcare ETF·ARCA
--
--(--)
--
--(--)
Key Stats
Assets Under Management
4.47BUSD
Fund Flows (1Y)
366.98MUSD
Dividend Yield
1.36%
Discount/Premium to NAV
-0.07%
Shares Outstanding
45.35M
Expense Ratio
0.40%
About iShares Global Healthcare ETF
Issuer
BlackRock Fund Advisors
Brand
iShares
Inception Date
Nov 13, 2001
Structure
Open-Ended Fund
Index Tracked
S&P Global 1200 Healthcare Sector Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
BlackRock Fund Advisors
Distributor
BlackRock Investments LLC
IXJ offers marketlike exposure to global pharmaceutical, biotechnology, and medical device companies. The fund pulls from the S&P Global 1200 universe, which effectively screens out small-caps, giving the fund a large-cap tilt compared to our benchmark. Aside from that, geographic and sector weights look neutral and make it a viable entry-point to global healthcare. BlackRock Fund Advisors uses a sampling approach to indexing. This means the fund may not hold all the stocks of the underlying index but will hold securities that collectively have the same investment profile. Stocks within IXJ are selected and weighted by float-adjusted market-cap. The index is rebalanced quarterly.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Broad-based
Strategy
Vanilla
Geography
Developed Markets
Weighting Scheme
Market Cap
Selection Criteria
Committee
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -0.91% | +8.06% | +0.92% | +9.01% | +23.47% | +36.24% |
NAV Total Return | +2.01% | +8.99% | +2.61% | +8.97% | +19.83% | +29.05% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
70.9%
23.47%
4.28%
1.25%
0.1%
Category
Ratio
North America
70.90%
Europe
23.47%
Asia
4.28%
Australasia
1.25%
Latin America
0.10%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Large-Cap Blend
Invests in large-cap companies with both growth and value characteristics. These ETFs offer diversified exposure to stable, well-established companies.
Top 10 Holdings
Symbol
Ratio
LLY
Eli Lilly
10.87%
JNJ
Johnson & Johnson
6.99%
ABBV
Abbvie
4.75%
ROCHE HOLDING PAR AG
4.03%
MRK
Merck
3.63%
ASTRAZENECA PLC
3.62%
NOVARTIS AG
3.59%
UNH
UnitedHealth Group
3.09%
TMO
Thermo Fisher
2.63%
AMGN
Amgen
2.44%
Top 10 Weight 45.64%
131 Total Holdings
Is SPY better than IXJ?
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-12-16 | 2025-12-16 | 2025-12-19 | 0.598 |
| 2025-06-16 | 2025-06-16 | 2025-06-20 | 0.763 |
| 2024-12-17 | 2024-12-17 | 2024-12-20 | 0.617 |
| 2024-06-11 | 2024-06-11 | 2024-06-17 | 0.672 |
| 2023-12-20 | 2023-12-21 | 2023-12-27 | 0.556 |
| 2023-06-07 | 2023-06-08 | 2023-06-13 | 0.644 |
| 2022-12-13 | 2022-12-14 | 2022-12-19 | 0.440 |
Show more
How Much Does IXJ Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy IXJ?
Fund Flows
